Background
Methods
Setting and data
Outcomes
Explanatory variables
Statistical analyses
Results
Descriptive statistics
First epidemic wave February 24 to June 5, 2020 | Second epidemic wave June 6, 2020, to March 1, 2021 | |||||
---|---|---|---|---|---|---|
No. of patients | Deaths | % | No. of patients | Deaths | % | |
Total | 3696 | 897 | 24.3% | 18,952 | 3888 | 20.5% |
Sex | ||||||
Female | 1456 | 292 | 20.1% | 8099 | 1381 | 17.1% |
Male | 2240 | 605 | 27.0% | 10,853 | 2507 | 23.1% |
Age [years] | ||||||
Median (IQR) | 73 (59–82) | 81 (74–87) | 75 (63–83) | 82 (75–87) | ||
0–29 | 137 | 1 | 0.7% | 517 | 3 | 0.6% |
30–39 | 122 | 4 | 3.3% | 399 | 4 | 1.0% |
40–49 | 202 | 4 | 2.0% | 874 | 22 | 2.5% |
50–59 | 505 | 31 | 6.1% | 2009 | 98 | 4.9% |
60–69 | 624 | 94 | 15.1% | 3274 | 382 | 11.7% |
70–79 | 920 | 252 | 27.4% | 4976 | 1107 | 22.2% |
80–89 | 906 | 371 | 40.9% | 5360 | 1666 | 31.1% |
90+ | 280 | 140 | 50.0% | 1543 | 606 | 39.3% |
Comorbid conditions | ||||||
Presence of any condition | ||||||
No comorbid condition | 495 | 19 | 3.8% | 2288 | 88 | 3.8% |
Any comorbid condition | 3201 | 878 | 27.4% | 16,664 | 3800 | 22.8% |
Number of conditions | ||||||
0 | 495 | 19 | 3.8% | 2288 | 88 | 3.8% |
1 | 1184 | 149 | 12.6% | 5253 | 569 | 10.8% |
2 | 1006 | 254 | 25.2% | 4809 | 901 | 18.7% |
3+ | 1011 | 475 | 47.0% | 6602 | 2330 | 35.3% |
Presence of specific condition | ||||||
Cancer | 382 | 182 | 47.6% | 2203 | 795 | 36.1% |
Cardiovascular disease | 1244 | 534 | 42.9% | 8057 | 2561 | 31.8% |
Chronic kidney disease | 90 | 61 | 67.8% | 3803 | 1437 | 37.8% |
Chronic respiratory disease | 578 | 209 | 36.2% | 3135 | 960 | 30.6% |
Diabetes | 844 | 258 | 30.6% | 4875 | 1274 | 26.1% |
Hypertension | 1921 | 602 | 31.3% | 9781 | 2551 | 26.1% |
Immunosuppression | 153 | 63 | 41.2% | 1036 | 322 | 31.1% |
Obesity | 16 | 8 | 50.0% | 1844 | 430 | 23.3% |
Other | 1500 | 481 | 32.1% | 4657 | 1254 | 26.9% |
ICU occupancy | ||||||
Total ICU occupancy | ||||||
≤ 65.7%a | - | - | 1903 | 327 | 17.2% | |
65.8–72.8%a | - | - | 7622 | 1521 | 20.0% | |
72.9–76.9%a | - | - | 7537 | 1609 | 21.3% | |
> 76.9%a | - | - | 1890 | 431 | 22.8% |